Skip to Main Content

Wade S. Smith


Director of Neurovascular Services
Band member of Bubba's Taxi – on saxophone, guitar and vocals

Dr. Wade Smith, director of the UCSF Neurovascular Service, specializes in stroke prevention, management of acute stroke, critical care medicine and medical management after stroke. He has expertise in transcranial Doppler techniques for cerebral blood-flow monitoring. As a neurointensivist – a specialist in both critical care and neurology – he directs UCSF's 16-bed neurological intensive care unit, dedicated to patients with neurological injuries. He evaluates many patients who have been referred for a second or third opinion, though he also evaluates patients who are seeing a neurologist for the first time.

Smith earned both his medical degree and a doctorate in neurophysiology from the University of Washington. He completed a residency as well as a fellowship in critical care medicine at UCSF.

  • Education

    University of Washington, 1989

  • Residencies

    UCSF, Neurology, 1993

  • Fellowships

    UCSF, Critical Care, 1994

  • Board Certifications

    Neurology, American Board of Psychiatry and Neurology.

  • Academic Title


I want to ensure that anyone having a stroke in our country can get rapid access to the best care possible, as patients do at UCSF.

Clinics I work with

Stroke Clinic

400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143

Vascular Laboratory

Cardiovascular Care & Prevention Center

400 Parnassus Ave., Fifth Floor, Suite 501
San Francisco, CA 94143

My reviews


Overall Experience
63 Ratings
Explained things in a way that was easy to understand
63 Ratings
Did the doctor pay attention to your concerns
63 Ratings
Gave easy to understand instructions about taking care of health problems or concerns
62 Ratings
Knew the important information about your medical history
63 Ratings
The provider showed respect for what you had to say
63 Ratings
The provider spent enough time with me
62 Ratings
Decorative Caduceus

Multi-arm Optimization of Stroke Thrombolysis


Decorative Caduceus

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

Recurrent stroke of any type (ischemic, hemorrhagic, or of unclear type)


Decorative Caduceus

Sleep for Stroke Management and Recovery Trial

The primary outcome is a time-to-event outcome defined as a participant having at least one of the following events within 6-months from randomization: new ischemic stroke, acute coronary syndrome or all-cause mortality